Epitalon Dosage Guide
Evidence-based protocols for the telomerase-activating tetrapeptide — intensive cycling, melatonin restoration, longevity stacking, and what the research actually shows.
In This Guide
A leading innovator in research chemicals.
|Exclusive OfferUse our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.
Shop NowFor research purposes only. PeptideWiki may earn a commission at no extra cost to you.
Epitalon
For research purposes only. PeptideWiki may earn a commission at no extra cost to you.
What Is Epitalon?
Epitalon (also written as Epithalon or Epithalone; sequence Ala-Glu-Asp-Gly) is a synthetic tetrapeptide based on the natural peptide Epithalamin, originally isolated from the pineal gland by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is one of the most researched peptides in the field of telomere biology and bioregulation.
Epitalon's primary mechanism of action is the activation of telomerase — the enzyme responsible for maintaining and elongating telomeres, the protective caps at the ends of chromosomes. Telomere shortening is one of the hallmarks of cellular aging, and telomerase reactivation in somatic cells has been a major target of longevity research. Khavinson's group demonstrated that Epitalon can induce telomerase activity in human somatic cells in vitro and promote telomere elongation.
Beyond telomerase activation, Epitalon stimulates pineal gland function and restores melatonin production — particularly relevant in aging, where pineal calcification and declining melatonin levels disrupt circadian rhythms and sleep quality. The peptide also demonstrates neuroendocrine regulatory effects and potential antioxidant properties in animal models.
What makes Epitalon's dosing protocol unique among peptides is its use in short, intensive cycles (10–20 days) repeated only 2–3 times per year. This is a fundamental departure from peptides like BPC-157 or Ipamorelin that are typically dosed daily for weeks or months. The cycling approach is based directly on Khavinson's clinical protocols.
Use our Peptide Dosage to calculate your exact dose based on vial size and concentration.
Key Characteristics:
- Synthetic tetrapeptide — 4 amino acids: Ala-Glu-Asp-Gly — based on the natural pineal peptide Epithalamin
- Telomerase activation — induces telomerase activity in human somatic cells, promoting telomere elongation in vitro (Khavinson et al.)
- Pineal gland stimulation — restores melatonin production and circadian rhythm regulation, especially relevant in age-related pineal decline
- Short intensive cycling — 10–20 day cycles repeated 2–3 times per year — NOT continuous daily use like most peptides
- Short half-life (minutes) — rapidly cleared from circulation, but telomerase activation and biological effects persist well beyond the injection period
- Subcutaneous injection — primary route of administration; some protocols use intranasal, though evidence is stronger for injection
For a complete overview of its mechanism and research, see our full Epitalon profile. New to peptides? Start with the Beginner's Guide to Peptides.
How Epitalon Dosage Is Determined
Epitalon dosing protocols are derived primarily from the clinical and experimental work of Professor Vladimir Khavinson and colleagues, spanning several decades of research at the St. Petersburg Institute of Bioregulation and Gerontology. The dosing parameters are more standardized than many research peptides because they originate from a consistent body of clinical work — though this work is largely from a single research group.
Khavinson's Clinical Protocols
Khavinson's research established the core protocol: 5–10 mg per day administered by injection for 10–20 consecutive days, constituting one course. This was repeated 2–3 times per year. The original work used Epithalamin (the pineal gland extract), and later studies transitioned to the synthetic tetrapeptide Epitalon (Ala-Glu-Asp-Gly) at equivalent dosing. Studies on elderly patients demonstrated restoration of melatonin production, improved immune markers, and normalization of neuroendocrine function.
Telomerase Activation Studies
Khavinson and Linnankivi demonstrated in vitro that Epitalon activates telomerase in human fetal fibroblast cultures and pulmonary cells, with observable telomere elongation. These studies confirmed that the tetrapeptide sequence Ala-Glu-Asp-Gly is the active component responsible for the telomerase-inducing effects previously attributed to the crude Epithalamin extract. The effective concentrations in cell culture informed the clinical dosing range.
Animal Longevity Studies
Multiple animal studies from Khavinson's group reported increased lifespan in rodent and Drosophila models treated with Epitalon or Epithalamin. Anisimov et al. published data showing extension of mean and maximum lifespan in rats, along with reduced incidence of spontaneous tumors. These animal models used dosing schedules analogous to the human cycling protocol — short treatment courses repeated periodically.
Community Protocol Refinement
The peptide research community has largely adopted Khavinson's published protocols with minor variations. The most common community protocol is 10 mg per day for 10 consecutive days, repeated every 6 months. Some users extend to 20-day cycles or increase frequency to 3 times per year. These variations remain within the general framework established by the original research.
Standard Epitalon Dosage Ranges
Epitalon is administered by subcutaneous injection during short intensive cycles. Unlike most peptides where dosing is measured in micrograms (mcg), Epitalon is dosed in milligrams (mg). The standard range is 5–10 mg per day for 10–20 consecutive days.
Dosage by Protocol Level
| Level | Daily Dose | Cycle Length | Cycles per Year | Notes |
|---|---|---|---|---|
| Conservative | 5 mg | 10 days | 2x per year | Minimum effective protocol; ideal for first-time users |
| Standard | 10 mg | 10 days | 2–3x per year | Most commonly used protocol; aligns with Khavinson's clinical dosing |
| Extended | 10 mg | 20 days | 2x per year | Longer cycle; used by experienced users seeking maximum exposure per course |
| Split-Dose | 5 mg × 2 | 10–20 days | 2–3x per year | Same daily total (10 mg) split into morning and evening injections |
Injection Timing
- Single daily dose (10 mg): Evening injection 1–2 hours before bed is preferred by many users to align with natural melatonin production
- Split dose (5 mg × 2): Morning + evening injections; may provide more sustained peptide exposure throughout the day
- No fasting requirement: Unlike GHRPs, Epitalon does not need to be injected on an empty stomach — its mechanism of action is not affected by food intake
- Consistency matters: Inject at approximately the same time each day throughout the cycle for consistent plasma levels
Epitalon Cycling Protocols
Cycling is the defining feature of Epitalon use. Unlike most peptides where cycling is optional or used to manage receptor desensitization, Epitalon's cycling protocol is integral to how the peptide was designed to be used. The rationale is that telomerase activation and pineal gland stimulation produce effects that persist well beyond the injection period — a short intensive course triggers biological processes that unfold over months.
Annual Cycling Schedules
| Schedule | Cycle Length | Frequency | Total Days per Year | Notes |
|---|---|---|---|---|
| Biannual | 10 days | Every 6 months | 20 days | Simplest schedule; e.g., January and July |
| Triannual | 10 days | Every 4 months | 30 days | More frequent exposure; e.g., January, May, September |
| Extended Biannual | 20 days | Every 6 months | 40 days | Longer cycles for maximum exposure; experienced users |
Why Short Cycles Work for Epitalon
Epitalon's mechanism differs fundamentally from peptides that require sustained receptor stimulation. Telomerase activation is a catalytic process — once the enzyme is activated in cells, the telomere elongation process continues independently of continued peptide exposure. Similarly, stimulation of the pineal gland initiates restoration of melatonin secretion patterns that persist after the injection course ends. The short cycle provides the initial stimulus; the biology does the rest.
This is analogous to Khavinson's broader theory of bioregulation, where short peptide courses “reset” or “normalize” cellular functions rather than providing continuous pharmacological stimulation. Whether this theoretical framework is fully validated remains an area of ongoing research, but the practical cycling protocols have been consistently used across decades of published studies.
Calculate Your Epitalon Dose
Epitalon is supplied as a lyophilized (freeze-dried) powder, typically in 10 mg or 50 mg vials. You reconstitute it with bacteriostatic water, then draw your dose using an insulin syringe. Because Epitalon is dosed in milligrams (not micrograms), the volumes per injection are somewhat larger than with peptides like Ipamorelin or BPC-157.
Worked Example:
- Vial size: 10 mg (10,000 mcg) of Epitalon
- Bacteriostatic water added: 2 mL
- Concentration: 10 mg ÷ 2 mL = 5 mg per mL
- Target dose: 10 mg
- Volume to draw: 10 ÷ 5 = 2 mL = the entire vial (one vial per day at this concentration)
At 10 mg/day from 10 mg vials, you will use one vial per day. For a 10-day cycle you need 10 vials. Larger vials (50 mg) are more cost-effective for multiple cycles.
Quick Reference — 10 mg Vial
| Bac Water Added | Concentration | 5 mg Dose | 10 mg Dose |
|---|---|---|---|
| 1 mL | 10 mg/mL | 50 units (0.5 mL) | 100 units (1 mL) — full vial |
| 2 mL | 5 mg/mL | 100 units (1 mL) | 200 units (2 mL) — full vial |
Quick Reference — 50 mg Vial
| Bac Water Added | Concentration | 5 mg Dose | 10 mg Dose |
|---|---|---|---|
| 2.5 mL | 20 mg/mL | 25 units (0.25 mL) | 50 units (0.5 mL) |
| 5 mL | 10 mg/mL | 50 units (0.5 mL) | 100 units (1 mL) |
| 10 mL | 5 mg/mL | 100 units (1 mL) | 200 units (2 mL) |
Skip the Math — Use Our
Enter your vial size, water volume, and desired dose — get instant calculations with zero manual math.
Epitalon Dosage by Goal
Epitalon's applications center on longevity, cellular health, and neuroendocrine restoration. While the core dosing protocol remains the same across goals (short intensive cycles), the emphasis, stacking partners, and expected timeline differ.
Telomere Maintenance & Longevity
The primary use case for Epitalon. Targets telomerase activation to maintain telomere length and support cellular longevity. This is a long-term strategy measured in years — the goal is cumulative benefit from repeated cycling over time.
- Dose: 10 mg per day (SubQ)
- Cycle: 10–20 days
- Frequency: 2–3 times per year, indefinitely
- Stack: GHK-Cu (skin/collagen anti-aging) + Thymosin Alpha-1 (immune longevity)
- Timeline: Evaluate over 1–2+ years of consistent cycling; telomere effects are cumulative
Sleep Quality & Circadian Rhythm Restoration
Targets Epitalon's pineal gland stimulation and melatonin production restoration. This is often the first noticeable benefit — improved sleep quality, easier sleep onset, and more consistent circadian rhythms. Particularly relevant for older adults with declining pineal function.
- Dose: 5–10 mg per day (SubQ)
- Cycle: 10 days
- Frequency: 2–3 times per year
- Timing: Evening injection (1–2 hours before bed) to align with natural melatonin rhythm
- Note: Sleep improvements may be noticeable within the first week of a cycle and often persist for weeks to months after the cycle ends
Neuroendocrine Restoration & Anti-Aging
Broader anti-aging protocol targeting Epitalon's neuroendocrine regulatory effects, including normalization of hormonal rhythms, immune function support, and antioxidant effects observed in Khavinson's clinical studies. Best combined with complementary peptides for a multi-system approach.
- Dose: 10 mg per day (SubQ)
- Cycle: 10–20 days
- Frequency: 2–3 times per year
- Stack: BPC-157 (systemic repair) + GHK-Cu (skin/collagen) + growth hormone secretagogue (e.g., Ipamorelin + CJC-1295)
Retinal Health Support
Khavinson's research group published studies on Epitalon's effects on retinal health, including potential benefits for retinal pigment epithelium in aging models. This is a more specialized application with limited clinical data, but it represents an active area of bioregulation research.
- Dose: 5–10 mg per day (SubQ)
- Cycle: 10 days
- Frequency: 2–3 times per year
- Note: Evidence is limited to Khavinson's group; consult an ophthalmologist before using Epitalon specifically for retinal concerns
Administration & Reconstitution
Epitalon is supplied as a white lyophilized (freeze-dried) powder. Proper reconstitution and storage are essential for maintaining peptide integrity, especially since Epitalon is a small tetrapeptide that can be susceptible to degradation.
Reconstitution Steps
- Clean the rubber stopper of the peptide vial and the bacteriostatic water vial with an alcohol swab
- Draw the desired volume of bacteriostatic water into a syringe (see dosing tables above for recommended volumes)
- Inject the water slowly into the peptide vial, aiming the stream against the glass wall — do not squirt directly onto the powder
- Gently swirl the vial until the powder dissolves completely — do not shake vigorously
- The solution should be clear and colorless. If cloudy or discolored, do not use
Storage Guidelines
| Form | Storage | Duration | Notes |
|---|---|---|---|
| Lyophilized powder | Freezer (–20°C) | 12+ months | Best for long-term storage; protect from light |
| Lyophilized powder | Refrigerator (2–8°C) | 3–6 months | Acceptable for shorter-term storage |
| Reconstituted solution | Refrigerator (2–8°C) | 3–4 weeks | Do not freeze reconstituted peptide; use within cycle |
Subcutaneous Injection Sites
- Abdominal fat (preferred): Pinch a fold of skin 1–2 inches from the navel, inject at a 45-degree angle using a 29–31 gauge insulin syringe
- Upper thigh: Front of the thigh, outer area — alternate with abdominal sites
- Upper arm: Back of the upper arm — may require assistance
- Rotate sites: Rotate injection sites throughout the cycle to minimize irritation
Intranasal Administration
Some users opt for intranasal Epitalon for convenience. Intranasal formulations are available from certain suppliers, typically as pre-made nasal sprays. However, the bioavailability via the intranasal route is less well-characterized for Epitalon specifically, and the vast majority of published research used subcutaneous or intramuscular injection. If choosing intranasal, doses may need adjustment and the evidence base is weaker.
Epitalon Stacking Protocols
Epitalon is commonly stacked with complementary peptides that target different longevity and anti-aging pathways. Because Epitalon's mechanism (telomerase activation, pineal stimulation) is unique, it does not compete with or overlap the mechanisms of most other peptides, making it a natural addition to multi-peptide longevity protocols.
Epitalon + GHK-Cu — The Anti-Aging Synergy Stack
Combines Epitalon's cellular-level anti-aging (telomerase activation) with GHK-Cu's tissue-level anti-aging (collagen synthesis, skin remodeling, wound healing, gene expression modulation). GHK-Cu influences over 4,000 genes and has well-documented skin rejuvenation and anti-inflammatory effects. Together they address aging at both the chromosomal and tissue levels.
Epitalon + BPC-157 (Longevity + Systemic Repair)
Combines Epitalon's longevity mechanism with BPC-157's broad systemic repair capabilities — angiogenesis, gut healing, tendon and ligament repair, and neuroprotection. This stack addresses both long-term cellular health (Epitalon) and active tissue repair (BPC-157). Particularly useful for users combining anti-aging with injury recovery.
Epitalon + Thymosin Alpha-1 (Longevity + Immune Restoration)
Combines telomerase activation with immune system restoration. Thymosin Alpha-1 enhances T-cell function, supports thymic output, and has been used clinically (as Zadaxin) for immune deficiency and hepatitis. This stack targets two critical systems that decline with age: telomere maintenance and immune competence.
| Compound | Dose | Frequency | Purpose |
|---|---|---|---|
| Epitalon | 10 mg SubQ | Daily for 10–20 days, 2–3x/year | Telomerase activation, pineal function, longevity |
| Thymosin Alpha-1 | 1.6 mg SubQ | 2x per week for 4–12 weeks | Immune restoration, T-cell enhancement, thymic support |
Comprehensive Longevity Stack (Multi-Pathway)
The most thorough anti-aging approach combines Epitalon with multiple complementary peptides, each targeting a different aging pathway. This is an advanced protocol for experienced users committed to a systematic, long-term longevity strategy.
| Compound | Dose | Target Pathway |
|---|---|---|
| Epitalon | 10 mg/day, 10–20 day cycles, 2–3x/year | Telomere maintenance, pineal function |
| GHK-Cu | 1–2 mg/day, 4–8 week cycles | Skin/collagen, gene expression, tissue remodeling |
| BPC-157 | 250–500 mcg/day, 4–8 week cycles | Systemic repair, gut health, angiogenesis |
| Ipamorelin + CJC-1295 | 200–300 mcg + 100 mcg, 1–2x daily | GH optimization, body composition, recovery |
Explore more combinations with our Peptide Stack Builder or browse the Top 10 Peptide Stacks guide.
Safety, Side Effects & Contraindications
Reported Side Effects
Rare and generally mild:
- Injection site reactions — mild redness, soreness, or swelling at the injection site (common to all subcutaneous peptides)
- Transient drowsiness — likely related to increased melatonin production; more common with evening injections (may actually be a desired effect)
- Mild headache — reported occasionally, typically during the first few days of a cycle and resolving spontaneously
- Mild flushing or warmth — reported by some users post-injection; generally transient
Theoretical concerns (not clinically observed):
- Telomerase activation and cancer risk — because cancer cells use telomerase to maintain their telomeres, there is a theoretical concern about promoting cancer. However, Khavinson's research actually reported antitumor effects in animal models. No clinical evidence links Epitalon to cancer promotion in humans, but the data is limited.
- Excessive melatonin production — theoretically possible, though not documented in published studies. Users taking exogenous melatonin should be aware of potential additive effects on sedation.
Contraindications
- Active cancer or recent cancer history — while Epitalon has not been shown to promote cancer, the theoretical concern about telomerase activation in cancer cells warrants avoidance. Individuals with active malignancies or recent cancer treatment should not use Epitalon until more definitive safety data is available.
- Pregnancy and breastfeeding — no safety data exists for Epitalon during pregnancy or nursing. Avoid entirely.
- Autoimmune conditions — Epitalon's immune-modulating effects (via pineal function and melatonin) may theoretically exacerbate autoimmune conditions. Consult a physician before use if you have an autoimmune disorder.
- Children and adolescents — Epitalon is intended for age-related applications. It has not been studied in pediatric populations and should not be used by individuals under 18.
Drug Interactions
No formal drug interaction studies have been published for Epitalon. However, the following considerations apply:
- Melatonin supplements: Epitalon may increase endogenous melatonin production. Concurrent use of melatonin supplements could result in excessive sedation. Consider reducing or temporarily discontinuing melatonin during Epitalon cycles.
- Sedating medications: The melatonin-enhancing effects may potentiate the sedation of benzodiazepines, sleep aids, or antihistamines. Monitor for excessive drowsiness.
- Immunosuppressants: Epitalon's immune-modulating properties could theoretically interact with immunosuppressive therapy. Consult your physician.
Common Epitalon Dosing Mistakes
Avoid these common errors to get the most out of your Epitalon protocol:
Frequently Asked Questions
Key Takeaways
- Epitalon (Ala-Glu-Asp-Gly) activates telomerase — the enzyme that maintains and elongates telomeres, addressing one of the key hallmarks of cellular aging
- Standard dose: 5–10 mg per day SubQ for 10–20 consecutive days, repeated 2–3 times per year
- Short intensive cycles are fundamental — Epitalon is NOT used continuously. The cycling protocol is based directly on Khavinson's clinical research spanning decades
- Melatonin restoration is often the first noticeable effect — improved sleep quality, circadian rhythm normalization, especially in older adults
- Telomere benefits are long-term and cumulative — evaluate over years of consistent cycling, not after a single course
- Best stacking partners: GHK-Cu (skin/tissue anti-aging), BPC-157 (systemic repair), Thymosin Alpha-1 (immune restoration)
- Very mild side effect profile — occasional injection site reactions, rare transient headache or drowsiness; no significant adverse effects reported in published studies
- Evidence caveat: Most research comes from Khavinson's group in Russia. The body of work is extensive and promising, but independent Western replication is limited
- No fasting requirement — unlike GHRPs, Epitalon's mechanism is not affected by food intake. Evening injection is preferred by many for melatonin alignment
- Not FDA-approved — classified as a research peptide worldwide. Check local regulations before purchasing.
This article is for educational and informational purposes only. See our Disclaimer.
References
- Khavinson VKh, et al. “Peptide Epitalon activates chromatin at the old age.” Neuro Endocrinol Lett. 2003;24(5):329-333. PubMed
- Khavinson VKh, et al. “Tetrapeptide AEDG (Epitalon) stimulates the expression of telomerase catalytic subunit gene (hTERT) in human somatic cells.” Bull Exp Biol Med. 2003;135(6):590-592. PubMed
- Anisimov VN, et al. “Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice.” Biogerontology. 2003;4(4):193-202. PubMed
- Khavinson VKh. “Peptides and Ageing.” Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PubMed
- Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology. 2010;11(2):139-149. PubMed
- Khavinson VKh, et al. “Effect of epithalon on the age-related dynamics of melatonin secretion in monkeys.” Bull Exp Biol Med. 2001;131(5):466-468. PubMed
- Kossoy G, et al. “Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors.” Int J Mol Med. 2003;12(4):473-477. PubMed
- Khavinson VKh, Morozov VG. “Peptides of pineal gland and thymus prolong human life.” Neuro Endocrinol Lett. 2003;24(3-4):233-240. PubMed
- Goncharova ND, et al. “Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas.” Exp Gerontol. 2005;40(1-2):51-57. PubMed
- Lin J, et al. “Telomere length measurement by qPCR — Summary of critical factors and recommendations for practice.” Environ Mol Mutagen. 2019;60(3):69-75.
- Blackburn EH, et al. “Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.” Nat Med. 2006;12(10):1133-1138. PubMed
Next Steps
Continue your research with these resources.
GHK-Cu Dosage Guide
Learn dosing protocols for GHK-Cu — the ideal anti-aging companion peptide for stacking with Epitalon.
Read GuideDosage Calculator
Calculate your exact Epitalon dose based on vial size and reconstitution volume.
Open CalculatorPeptide Directory
Browse all peptides with research summaries and dosing data.
View Directory